Auditory Development of Young Children with Profound Hearing Loss, Cochlear Implants, and Congenital CMV Infection
Journal of Clinical Medicine · 08.11.2024 · 13 (22) · 6734
DOI: 10.3390/jcm13226734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.11.2024. Verfasst von Piotr H Skarzynski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Teleaudiology and Screening Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, 02-042 Warsaw, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background/Objectives: The aim of this study was to assess auditory development in young children with profound hearing loss, cochlear implants (CIs), and congenital cytomegalovirus (cCMV) infection and to determine the effect of comorbidities on their development.
Methods
The study group (cCMV group) consisted of 47 CI children—18 girls and 29 boys—who had been diagnosed as having prelingual hearing loss due to cCMV infection (with or without comorbidities); the mean age at CI activation was 15.2 months (range: 9.7–23.8; SD = 3.5). The reference group (no cCMV) consisted of 117 similar children (57 girls and 60 boys) who had profound sensorineural hearing loss not caused by cCMV infection; they had no comorbidities. The mean age at CI activation in the second group was 14.3 months (range: 7.9–23.5; SD = 4.0). Auditory development in all children was assessed with the LittlEARS Auditory Questionnaire (LEAQ) at CI activation and at about 1, 5, 9, 14, and 24 months of CI use.
Results
The mean LEAQ total score increased over a similar time frame from 9.8 pts to 28.9 pts in the cCMV group without comorbidities, from 4.5 pts to 18.5 pts in the cCMV group with comorbidities, and from 9.2 to 31.6 pts in the reference group with no cCMV infection.
Conclusions
Early cochlear implantation in children with sensorineural hearing loss due to congenital CMV infection and no comorbidities promotes their early auditory development in a similar way to children without cCMV infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Teleaudiology and Screening Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, 02-042 Warsaw, Poland.
- Institute of Sensory Organs, 05-830 Kajetany, Poland.
- Implant and Auditory Perception Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, 02-042 Warsaw, Poland.
- Otorhinolaryngosurgery Clinic, World Hearing Center, Institute of Physiology and Pathology of Hearing, 02-042 Warsaw, Poland.
ORCID-Profile: Piotr H Skarzynski, Aleksandra Kolodziejak, Artur Lorens, Henryk Skarzynski
Zitieren
APA
Skarzynski, P. H., Obrycka, A., Kolodziejak, A., Lorens, A., Gos, E., Zdanowicz, R., & Skarzynski, H. (2024). Auditory Development of Young Children with Profound Hearing Loss, Cochlear Implants, and Congenital CMV Infection. Journal of Clinical Medicine, 13(22), 6734. https://doi.org/10.3390/jcm13226734
Vancouver
Skarzynski PH, Obrycka A, Kolodziejak A, Lorens A, Gos E, Zdanowicz R, et al. Auditory Development of Young Children with Profound Hearing Loss, Cochlear Implants, and Congenital CMV Infection. Journal of Clinical Medicine. 2024;13(22):6734. doi:10.3390/jcm13226734
BibTeX
@article{Skarzynski2024,
author = {Skarzynski, Piotr H and Obrycka, Anita and Kolodziejak, Aleksandra and Lorens, Artur and Gos, Elzbieta and Zdanowicz, Rita and Skarzynski, Henryk},
title = {Auditory Development of Young Children with Profound Hearing Loss, Cochlear Implants, and Congenital CMV Infection},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {22},
pages = {6734},
doi = {10.3390/jcm13226734}
}
EUVIMED